Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination
Open Access
- 11 June 2002
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (12) , 8207-8212
- https://doi.org/10.1073/pnas.122092499
Abstract
Myelin/oligodendrocyte glycoprotein (MOG) is a target antigen for myelin-destructive Abs in autoimmune central nervous system demyelinating disorders. Little is known about the molecular and structural basis of these pathogenic Ab responses. Here, we have characterized anti-MOG Ab specificities in the marmoset model of experimental allergic encephalomyelitis, by means of a combinatorial IgG-Fab library. We found that a diverse population of Ig genes encodes for auto-Abs that exclusively recognize conformation-dependent antigenic targets on MOG. These antigenic domains correspond to exposed epitopes in vivo, as the Fab fragments recognize native MOG in situ in marmoset brain tissue. The Ab fragments described here represent Ab specificities that are common constituents of the humoral immune repertoire against MOG in outbred populations, as demonstrated by their ability to displace native anti-MOG Abs present in sera from MOG-immune marmosets and patients with multiple sclerosis. Furthermore, neuropathological analysis and characterization of Ab epitope specificities in animals immunized with MOG or MOG-derived peptides revealed that only conformation-dependent Abs are associated with demyelinating activity, suggesting that epitope recognition is an important factor for Ab pathogenicity. Our findings provide novel and unexpected knowledge on the diversity of anti-MOG Ab responses in nonhuman primates and humans, and will permit the dissection of pathogenic auto-Ab properties in multiple sclerosis.Keywords
This publication has 32 references indexed in Scilit:
- Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.Journal of Clinical Investigation, 1998
- Late Complications of Immune Deviation Therapy in a Nonhuman PrimateScience, 1996
- Allergic Encephalomyelitis in Common Marmosets: Pathogenesis of a Multiple Sclerosis-like LesionMethods, 1996
- Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptidesInternational Immunology, 1996
- Mechanisms of Immune Injury in Multiple SclerosisBrain Pathology, 1996
- Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.Journal of Clinical Investigation, 1995
- T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous systemEuropean Journal of Immunology, 1993
- Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamilyJournal of Neuroscience Research, 1992
- Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controlsJournal of Neuroimmunology, 1991
- Affinity consideration in the design of synthetic vaccines intended to elicit antibodiesMolecular Immunology, 1989